151 related articles for article (PubMed ID: 11385617)
1. KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation.
Huard B; Karlsson L; Triebel F
Eur J Immunol; 2001 Jun; 31(6):1728-35. PubMed ID: 11385617
[TBL] [Abstract][Full Text] [Related]
2. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
[TBL] [Abstract][Full Text] [Related]
3. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
4. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
Sandusky MM; Messmer B; Watzl C
Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
[TBL] [Abstract][Full Text] [Related]
7. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
[TBL] [Abstract][Full Text] [Related]
8. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
[TBL] [Abstract][Full Text] [Related]
9. MHC class I-independent recognition of NK-activating receptor KIR2DS4.
Katz G; Gazit R; Arnon TI; Gonen-Gross T; Tarcic G; Markel G; Gruda R; Achdout H; Drize O; Merims S; Mandelboim O
J Immunol; 2004 Aug; 173(3):1819-25. PubMed ID: 15265913
[TBL] [Abstract][Full Text] [Related]
10. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
11. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
[TBL] [Abstract][Full Text] [Related]
13. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
[TBL] [Abstract][Full Text] [Related]
14. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
[TBL] [Abstract][Full Text] [Related]
15. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal age related change in natural killer cell receptors for MHC class I.
Lutz CT; Moore MB; Bradley S; Shelton BJ; Lutgendorf SK
Mech Ageing Dev; 2005; 126(6-7):722-31. PubMed ID: 15888327
[TBL] [Abstract][Full Text] [Related]
17. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
20. Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion.
Wang W; Erbe AK; Alderson KA; Phillips E; Gallenberger M; Gan J; Campana D; Hank JA; Sondel PM
Cancer Immunol Immunother; 2016 Sep; 65(9):1047-59. PubMed ID: 27392940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
